Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Goodwill (2016 - 2026)

Champions Oncology has reported Goodwill over the past 16 years, most recently at $335000.0 for Q1 2026.

  • For Q1 2026, Goodwill changed 0.0% year-over-year to $335000.0; the TTM value through Jan 2026 reached $335000.0, changed 0.0%, while the annual FY2025 figure was $335000.0, 0.0% changed from the prior year.
  • Goodwill for Q1 2026 was $335000.0 at Champions Oncology, roughly flat from $335000.0 in the prior quarter.
  • Over five years, Goodwill peaked at $335000.0 in Q1 2022 and troughed at $335000.0 in Q1 2022.
  • A 5-year average of $335000.0 and a median of $335000.0 in 2022 define the central range for Goodwill.
  • On a YoY basis, Goodwill climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
  • Year by year, Goodwill stood at $335000.0 in 2022, then changed by 0.0% to $335000.0 in 2023, then changed by 0.0% to $335000.0 in 2024, then changed by 0.0% to $335000.0 in 2025, then changed by 0.0% to $335000.0 in 2026.
  • Business Quant data shows Goodwill for CSBR at $335000.0 in Q1 2026, $335000.0 in Q4 2025, and $335000.0 in Q3 2025.